摘要
需要器官移植的患者经常经受不同的皮肤病,需要进行免疫抑制治疗。具体的皮肤副作用比如痤疮、多毛症或其他毛囊皮脂腺紊乱、牙龈增生、紫癜或毛细管扩张通常与免疫抑制介导有关。大部分情况是温和的,但是可能会影响患者的审美是生命的质量并且减少了治疗的依附性。此外,器官移植受体经常会受到皮肤感染,间接导致免疫抑制。疱疹病毒的再激活通常是移植后几个月,然而党减少免疫抑制之后,皮肤感染主要由人乳头状瘤宾度感染并且表现出局限性。很少有细菌感染。长期的免疫抑制治疗主要体现在肿瘤早期和皮肤癌的发展,这有一定的风险使得时间延长和对病人的存活有明显的影响。本文对近几年的文献报道的数据对该主题进行综述,为了了解器官移植受体患者与使用免疫抑制药物相关的主要皮肤紊乱的特征,包括其风险、流行病学、临床表现与管理方面的知识。
关键词: 皮肤,副作用,免疫抑制治疗,器官移植
图形摘要
Current Drug Targets
Title:Characterization and Management of Cutaneous Side Effects Related to the Immunosuppressive Treatment in Solid Organ Recipients
Volume: 18 Issue: 4
关键词: 皮肤,副作用,免疫抑制治疗,器官移植
摘要: Patients who underwent solid organ transplantation frequently suffer from different skin diseases, as consequence of the immunosuppressive treatment. Specific cutaneous side effects such as acne, hypertricosis or other pilosebaceous unit disorders, gingival hyperplasia, purpura or teleangiectasies are commonly associated to immunosuppressive medications. The majority of these conditions are benign, but the aesthetic concern may affect the patient is quality of life and reduce the adherence to the therapy. Moreover, solid organ transplant recipients frequently develop skin infections, as an indirect consequence of the immunosuppressive regimens. Herpes virus reactivation is more common few months after transplantation, whereas when the immunosuppression is reduced, the skin infections are mainly represented by human papilloma virus infections and localized mycosis. Bacterial infections are relatively rare. Long-term consequences of the immunosuppressive therapy are represented by development of precancerosis and skin cancers, with a risk that enhances over the time and a significant impact on patient survival. The aim of this paper is to provide an overview of the data published in the recent literature about this topic, in order to characterize the main skin disorders associated to the use of immunosuppressive drugs in solid organ recipients, giving information about their risk, epidemiology, clinical manifestations and management.
Export Options
About this article
Cite this article as:
Characterization and Management of Cutaneous Side Effects Related to the Immunosuppressive Treatment in Solid Organ Recipients, Current Drug Targets 2017; 18 (4) . https://dx.doi.org/10.2174/1389450117666160112115524
DOI https://dx.doi.org/10.2174/1389450117666160112115524 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Expanding Targets for a Metabolic Therapy of Cancer: L-Asparaginase
Recent Patents on Anti-Cancer Drug Discovery P53 Family: At the Crossroads in Cancer Therapy
Current Medicinal Chemistry Pegylated Liposomal Doxorubicin in Salvage Chemotherapy for Multiple Myeloma Patients
Current Cancer Therapy Reviews Morphological and Functional Characteristic of Senescent Cancer Cells
Current Drug Targets Medical Image Processing Technology for Diagnosing and Treating Cancers
Recent Patents on Biomedical Engineering (Discontinued) Nanomedicine and its Application in Treatment of Microglia-mediated Neuroinflammation
Current Medicinal Chemistry Drug Coated Clay Nanoparticles for Delivery of Chemotherapeutics
Current Nanoscience Breast Cancer Stem Cells and Intrinsic Subtypes: Controversies Rage On
Current Stem Cell Research & Therapy Anti-EGFRvIII Chimeric Antigen Receptor-Modified T Cells for Adoptive Cell Therapy of Glioblastoma
Current Pharmaceutical Design Cancer-Type Organic Anion Transporting Polypeptide 1B3: Current Knowledge of the Gene Structure, Expression Profile, Functional Implications and Future Perspectives
Current Drug Metabolism Vitiligo: An Updated Narrative Review
Current Pediatric Reviews Recent Progress in the Development of Histone Deacetylase Inhibitors as Anti-Cancer Agents
Mini-Reviews in Medicinal Chemistry Genetic and Epigenetic Studies for Determining Molecular Targets of Natural Product Anticancer Agents
Current Cancer Drug Targets The Association of Chemotherapy and Radiotherapy in Squamous Cell Carcinoma of Anal Canal
Current Drug Therapy Magnetic Resonance Imaging of Uncommon Hepatic Mesenchymal Tumours: Haemangioendothelioma and Angiosarcoma
Current Medical Imaging Structure and Design of Polycationic Carriers For Gene Delivery
Mini-Reviews in Medicinal Chemistry B-Cell Based Gene Therapy for Inducing Tolerance
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry NO News is not Necessarily Good News in Cancer
Current Cancer Drug Targets Pharmacological Modulation of Th17
Recent Patents on Inflammation & Allergy Drug Discovery Medical Treatment of Gastrointestinal Stromal Tumors: State of the Art and Future Perspectives
Reviews on Recent Clinical Trials